Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibing Wang

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Bioscience Reports|June 1, 2021
Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomesJiaying Lou, Jialin Dong, Ruijun Xu, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|June 17, 2011
[Preventive effect of polypropylene mesh bonded norvancomycin slow-release microsphere on Staphylococcus aureus infection of incisional hernia repair model]Feide Liu, Lili Gao, Tianjun Liu, et al.
Blood Cancer Journal|March 1, 2022
CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphomaWen Lei, Qian Ye, Yuanyuan Hao, et al.
Oncology Letters|August 14, 2020
The TGF-β1/COX-2-dependant pathway serves a key role in the generation of OKC-induced M2-polarized macrophage-like cells and angiogenesisGang Cheng, Jinxing Gao, Lianfei Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2023
Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin's suppression of oral cancerHui Dong, Mengli Li, Hong Chen, et al.
Cancer Cell International|August 1, 2021
A review on the advances and challenges of immunotherapy for head and neck cancerGang Cheng, Hui Dong, Chen Yang, et al.
Oncology Reports|January 20, 2021
Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivoShufang Xie, Weimin Fan, Chen Yang, et al.
Oncotargets and Therapy|November 2, 2016
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirusShibing Wang, Jing Shu, Li Chen, et al.
Oncotargets and Therapy|November 10, 2018
Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virusJiamin Peng, Shibing Wang, Weimin Fan, et al.
Oncology Reports|October 27, 2018
Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancerWanyuan Chen, Weimin Fan, Guoqing Ru, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Bioscience Reports|June 1, 2021
Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomesJiaying Lou, Jialin Dong, Ruijun Xu, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|June 17, 2011
[Preventive effect of polypropylene mesh bonded norvancomycin slow-release microsphere on Staphylococcus aureus infection of incisional hernia repair model]Feide Liu, Lili Gao, Tianjun Liu, et al.
Blood Cancer Journal|March 1, 2022
CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphomaWen Lei, Qian Ye, Yuanyuan Hao, et al.
Oncology Letters|August 14, 2020
The TGF-β1/COX-2-dependant pathway serves a key role in the generation of OKC-induced M2-polarized macrophage-like cells and angiogenesisGang Cheng, Jinxing Gao, Lianfei Wang, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2023
Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin's suppression of oral cancerHui Dong, Mengli Li, Hong Chen, et al.
Cancer Cell International|August 1, 2021
A review on the advances and challenges of immunotherapy for head and neck cancerGang Cheng, Hui Dong, Chen Yang, et al.
Oncology Reports|January 20, 2021
Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivoShufang Xie, Weimin Fan, Chen Yang, et al.
Oncotargets and Therapy|November 2, 2016
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirusShibing Wang, Jing Shu, Li Chen, et al.
Oncotargets and Therapy|November 10, 2018
Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virusJiamin Peng, Shibing Wang, Weimin Fan, et al.
Oncology Reports|October 27, 2018
Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancerWanyuan Chen, Weimin Fan, Guoqing Ru, et al.
Pageof 7